Banton Jane
University of Wisconsin Hospital and Clinics, 600 Highland Ave., Madison, WI 53792, USA.
Nutr Clin Pract. 2006 Feb;21(1):56-61. doi: 10.1177/011542650602100156.
Central venous catheters (CVCs) are commonly used to deliver a variety of therapies such as chemotherapy and parenteral nutrition. It is well known that there are complications associated with CVCs; a major complication is catheter-related bloodstream infection (CRBSI). Many strategies exist to prevent CVC complications and CRBSI. This paper will focus on the fight against CRBSI using 3 products at the catheter insertion site: 2% chlorhexidine, BioPatch, and transparent split dressings. Lists of key recommendations from national organizations for infection prevention are included.
中心静脉导管（CVC）常用于实施多种治疗，如化疗和肠外营养。众所周知，CVC存在相关并发症；主要并发症是导管相关血流感染（CRBSI）。有多种预防CVC并发症和CRBSI的策略。本文将聚焦于在导管插入部位使用三种产品对抗CRBSI：2%洗必泰、生物贴片和透明分体敷料。文中还包含了国家组织预防感染的关键建议清单。
